Board of Directors

Tarek Sherif

A founder of Medidata Solutions, Tarek has served as CEO since 2001 and chairman since 2009. Including Medidata’s successful public offering in 2009, Tarek has led Medidata from startup to becoming the leading global provider of cloud-based solutions to the life science industry and one of the largest public technology companies founded in New York City.  Medidata is the global leader in collecting and managing clinical trial data and supports trials in more than 120 countries, while defining the vertical cloud company business model. Medidata’s mission is to power smarter treatments and healthier people.

Tarek has more than 30 years of leadership experience in health-tech and finance. Prior to Medidata, he co-managed and managed equity funds focused on public and private technology and life sciences companies, as well as holding various positions in finance.

Tarek received his BA in economics from Yale University in 1984 and graduated from Columbia Business School in 1991, where he earned a degree in business administration and finance. He serves as the co-chair of the Partnership Fund for New York City, which is focused on creating business opportunities and jobs for city residents. Tarek also sits on the advisory board of Students on Ice, a not-for-profit organization focused on inspiring youth through educational expeditions to the polar regions,​ the Musculoskeletal Advisory Board at NYU Langone Medical Center​, ​and Defy Ventures—a New York-based non-profit dedicated to​ providing business leadership ​training ​and entrepreneurial ​education to​ people with criminal histories.

Glen de Vries

Glen is the president and co-founder of Medidata, and the original architect of Medidata's cloud platform. With his deep expertise in medical research and understanding of technology’s role in streamlining complex processes, Glen has been driving Medidata's mission since the company’s inception: Powering smarter treatments and healthier people.

Glen received his BS in molecular biology and genetics from Carnegie Mellon University, worked as a research scientist at the Columbia Presbyterian Medical Center and studied computer science at New York University's Courant Institute of Mathematics. He is the holder of numerous patents for clinical trial innovations, and is a member of the board of the Young Scientist Foundation and chairman of the board of Dancing Classrooms.

You can follow Glen on Twitter at @CaptainClinical.

Carlos Dominguez

As the president and COO of Sprinklr, Carlos leads the marketing, sales, services and partnerships organizations as well as guides the strategic vision for the company. Carlos previously spent 22 years at Cisco Systems, Inc., where he helped build Cisco's multi-billion dollar service provider business. A technology visionary and an early adopter of social media, Carlos has deep insight into how communications and collaboration can transform organizations, engage customers and revitalize communities.

A passionate technology evangelist, Carlos speaks to audiences worldwide about leadership, innovation, collaboration, social media, and how new technologies, as they converge, will shape the ways we work, live, play and learn in the future.

Neil Kurtz MD

Neil has served on Medidata's board of directors since 2002. He also serves on the board of directors of TeamHealth, the nation’s leading provider of emergency department services.

Currently, Neil is president and CEO of Golden Living, a leading provider of long-term care. He was president and CEO of Worldwide Clinical Trials, an international clinical research operation purchased by United HealthGroup in 1999.

He holds a BA in psychology from New York University and an MD from the Medical College of Wisconsin.

George McCulloch

George has served as a director of Medidata since 2004. He is co-CEO of Level Equity Management, LLC, a private investment firm he founded that invests in growth-stage software and Internet businesses.

George was previously a managing director at Insight Venture Partners and a member of the technology investment team at Summit Partners. He is a director of various privately-held technology businesses and a trustee of ARTstor, a non-profit initiative founded by The Andrew W. Mellon Foundation that builds technology to enhance teaching and learning in the arts.

He holds a BA from Stanford University.

Lee Shapiro

Lee Shapiro is managing partner at 7wire Ventures, a growth capital firm that invests in healthcare, energy and education. Prior to 7wire, Lee was with Allscripts for over 13 years and served as president from 2001 through 2012. During his tenure, Allscripts grew from $30M to over $1.3B in revenues.

Lee brings to our board of directors significant experience in directing strategic initiatives at a global public healthcare technology company. He holds a BA in accounting from the University of Illinois Urbana-Champaign and earned his JD from the University of Chicago Law School.

Robert B. Taylor

Bob has served on Medidata’s board of directors since April 2008 and was appointed lead director in July 2015. He recently retired from serving as senior vice president for finance and administration for The Colonial Williamsburg Foundation, a nonprofit, tax-exempt, educational organization in Williamsburg, Virginia.

Bob has served on the boards of a wide range of for-profit companies and charitable organizations. Prior to joining The Colonial Williamsburg Foundation, Bob served as vice president and treasurer of Wesleyan University. He holds a BA, magna cum laude, from St. Lawrence University.

 

Stock Quote

  • NASDAQ: MDSO
  • 54.13 Price:
  • 0.08 Change:
  • 54.36 Day High:
  • 53.52 Day Low:
  • 360,790 Volume:

Investor Contact

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com